Table 2.
Effect of in utero GEN exposure on body weight, absolute and relative spleen weight in middle-aged B6C3F1 offspring
PND | Parameters | Naïve | Vehicle | Genistein | |
---|---|---|---|---|---|
Female | 240 | Body wt (g) | 33.43 ± 1.88 | 35.12 ± 2.59 | 33.93 ± 1.74 |
(7) | (6) | (7) | |||
Spleen (mg) | 81.25 ± 2.46 | 105.50 ± 8.79 a | 87.86 ± 2.76 b | ||
%Body Wt | 0.244 ± 0.014 | 0.307 ± 0.030 | 0.263 ± 0.018 | ||
290 | Body wt (g) | 43.49 ± 2.38 | 41.02 ± 1.59 | 39.91 ± 1.96 | |
(8) | (6) | (7) | |||
Spleen (mg) | 106.88 ± 8.82 | 113.83 ± 5.64 | 98.14 ± 5.32 | ||
%Body Wt | 0.247 ± 0.016 | 0.279 ± 0.017 | 0.253 ± 0.025 | ||
330 | Body wt (g) | 42.16 ± 2.06 | 40.97 ± 2.74 | 36.43 ± 2.42 | |
(8) | (6) | (7) | |||
Spleen (mg) | 105.50 ± 5.27 | 103.17 ± 2.65 | 126.29 ± 8.74 b | ||
%Body Wt | 0.253 ± 0.016 | 0.258 ± 0.018 | 0.356 ± 0.032 a,b | ||
Male | 240 | Body wt (g) | 44.48 ± 0.97 | 41.79 ± 0.30 a | 42.17 ± 0.72 |
(8) | (8) | (8) | |||
Spleen (mg) | 89.63 ± 5.15 | 80.63 ± 1.59 | 80.25 ± 2.85 | ||
%Body Wt | 0.201 ± 0.009 | 0.193 ± 0.005 | 0.190 ± 0.006 | ||
290 | Body wt (g) | 46.25 ± 1.29 | 43.98 ± 0.91 | 43.34 ± 0.46 a | |
(6) | (8) | (8) | |||
Spleen (mg) | 99.17 ± 5.84 | 90.25 ± 6.26 | 95.25 ± 3.00 | ||
%Body Wt | 0.214 ± 0.008 | 0.204 ± 0.011 | 0.220 ± 0.006 | ||
330 | Body wt (g) | 47.66 ± 1.18 | 44.25 ± 0.67 a | 43.29 ± 0.87 a | |
(8) | (8) | (8) | |||
Spleen (mg) | 113.13 ± 9.86 | 110.13 ± 10.25 | 105.88 ± 5.73 | ||
%Body Wt | 0.236 ± 0.016 | 0.249 ± 0.023 | 0.244 ± 0.010 |
Pregnant mice were treated with genistein or vehicle from GD14 to birth by gavage. Female or male offspring were sacrificed at three different time points (PND 240, 290, and 330) following HDM dosing, and their body weight and spleens were weighed. Naive = untreated, non-sensitized naïve animals.
significantly different from naive;
significantly different from vehicle. The number in parenthesis indicates the number in each group.